EIF4G1 mutations do not cause Parkinson's disease

Neurobiology of Aging

Volumn 36, Issue 8, 2015, Pages 2444.e1-2444.e4

  Nichols, Noah ^a   Bras, Jose M ^b   Hernandez, Dena G ^a,b   Jansen, Iris E ^c,d   Lesage, Suzanne ^e   Lubbe, Steven ^b   Singleton, Andrew B ^a   International Parkinson's Disease Genomics Consortium, ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

EIF4G1; Genetics; Mutation; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EIF4G1 GENE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; MUTATIONAL ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETICS; MUTATION;

EIF4G1 PROTEIN, HUMAN; INITIATION FACTOR 4G;

EUKARYOTIC INITIATION FACTOR-4G; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; MUTATION; PARKINSON DISEASE;

EID: 84952636767     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.04.017     Document Type: Article

References (11)

1. Blanckenberg J., Ntsapi C., Carr J.A., Bardien S. EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa. Neurobiol. Aging 2014, 35:445.e1-445.e3.
2. Chartier-Harlin M.C., Dachsel J.C., Vilariño-Güell C., Lincoln S.J., Leprêtre F., Hulihan M.M., Kachergus J., Milnerwood A.J., Tapia L., Song M.S., Le Rhun E., Mutez E., Larvor L., Duflot A., Vanbesien-Mailliot C., Kreisler A., Ross O.A., Nishioka K., Soto-Ortolaza A.I., Cobb S.A., Melrose H.L., Behrouz B., Keeling B.H., Bacon J.A., Hentati E., Williams L., Yanagiya A., Sonenberg N., Lockhart P.J., Zubair A.C., Uitti R.J., Aasly J.O., Krygowska-Wajs A., Opala G., Wszolek Z.K., Frigerio R., Maraganore D.M., Gosal D., Lynch T., Hutchinson M., Bentivoglio A.R., Valente E.M., Nichols W.C., Pankratz N., Foroud T., Gibson R.A., Hentati F., Dickson D.W., Destée A., Farrer M.J. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am. J. Hum. Genet. 2011, 89:398-406.
3. Chen Y., Chen K., Song W., Chen X., Cao B., Huang R., Zhao B., Guo X., Burgunder J., Li J., Shang H.F. VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from Southwest China. Neurobiol. Aging 2013, 34:1709.e7-1709.e8.
4. Dhungel N., Eleuteri S., Li L.B., Kramer N.J., Chartron J.W., Spencer B., Kosberg K., Fields J.A., Stafa K., Adame A., Lashuel H., Frydman J., Shen K., Masliah E., Gitler AD. Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein. Neuron 2015, 85:657.
5. Fujioka S., Sundal C., Strongosky A.J., Castanedes M.C., Rademakers R., Ross O.A., Vilariño-Güell C., Farrer M.J., Wszolek Z.K., Dickson D.W. Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia. Acta Neuropathol. 2013, 125:425-438.
6. Huttenlocher J., Krüger R., Capetian P., Lohmann K., Brockmann K., Csoti I., Klein C., Berg D., Gasser T., Bonin M., Riess O., Bauer P. EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohorts. J. Med. Genet. 2014, November. doi:10.1136/jmedgenet-2014-102570.
7. Lesage S., Condroyer C., Klebe S., Lohmann E., Durif F., Damier P., Tison F., Anheim M., Honoré A., Viallet F., Bonnet A.M., Ouvrard-Hernandez A.M., Vidailhet M., Durr A., Brice A. EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants?. Neurobiol. Aging 2012, 33:2233.e1-2233.e5. French Parkinson's Disease Genetics Study Group.
8. Nalls, M.A., Pankratz, N., Lill, C.M., Do, C.B., Hernandez, D.G., Saad, M., DeStefano, A.L., Kara E., Bras J., Sharma M., Schulte C., Keller M.F., Arepalli S., Letson C., Edsall C., Stefansson H., Liu X., Pliner H., Lee J.H., Cheng R.; International Parkinson's Disease Genomics Consortium (IPDGC); Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI); 23andMe; GenePD; NeuroGenetics Research Consortium (NGRC); Hussman Institute of Human Genomics (HIHG); Ashkenazi Jewish Dataset Investigator; Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE); North American Brain Expression Consortium (NABEC); United Kingdom Brain Expression Consortium (UKBEC); Greek Parkinson's Disease Consortium; Alzheimer Genetic Analysis Group, Ikram M.A., Ioannidis J.P., Hadjigeorgiou G.M., Bis J.C., Martinez M., Perlmutter J.S., Goate A., Marder K., Fiske B., Sutherland M., Xiromerisiou G., Myers R.H., Clark L.N., Stefansson K., Hardy J.A., Heutink P., Chen H., Wood N.W., Houlden H., Payami H., Brice A., Scott W.K., Gasser T., Bertram L., Eriksson N., Foroud T., Singleton A.B., 2014. Largescale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat. Genet. 46, 989-993.
9. Nishioka K., Funayama M., Vilariño-Güell C., Ogaki K., Li Y., Sasaki R., Kokubo Y., Kuzuhara S., Kachergus J.M., Cobb S.A., Takahashi H., Mizuno Y., Farrer M.J., Ross O.A., Hattori N. EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population. Parkinsonism Relat. Disord. 2014, 20:659-661.
10. Siitonen A., Majounie E., Federoff M., Ding J., Majamaa K., Singleton A.B. Mutations in EIF4G1 are not a common cause of Parkinson's disease. Eur. J. Neurol. 2013, 20:e59.
11. Tucci A., Charlesworth G., Sheerin U.M., Plagnol V., Wood N.W., Hardy J. Study of the genetic variability in a Parkinson's disease gene: EIF4G1. Neurosci. Lett. 2012, 518:19-22.